Cargando…
Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach
INTRODUCTION: Benzodiazepines are the most commonly prescribed psychotropic medications, but they may place users at risk of serious adverse effects. Developing a method to predict benzodiazepine prescriptions could assist in prevention efforts. METHODS: The present study applies machine learning me...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036348/ https://www.ncbi.nlm.nih.gov/pubmed/36970256 http://dx.doi.org/10.3389/fpsyt.2023.1087879 |
_version_ | 1784911632222126080 |
---|---|
author | Kinney, Kerry L. Zheng, Yufeng Morris, Matthew C. Schumacher, Julie A. Bhardwaj, Saurabh B. Rowlett, James K. |
author_facet | Kinney, Kerry L. Zheng, Yufeng Morris, Matthew C. Schumacher, Julie A. Bhardwaj, Saurabh B. Rowlett, James K. |
author_sort | Kinney, Kerry L. |
collection | PubMed |
description | INTRODUCTION: Benzodiazepines are the most commonly prescribed psychotropic medications, but they may place users at risk of serious adverse effects. Developing a method to predict benzodiazepine prescriptions could assist in prevention efforts. METHODS: The present study applies machine learning methods to de-identified electronic health record data, in order to develop algorithms for predicting benzodiazepine prescription receipt (yes/no) and number of benzodiazepine prescriptions (0, 1, 2+) at a given encounter. Support-vector machine (SVM) and random forest (RF) approaches were applied to outpatient psychiatry, family medicine, and geriatric medicine data from a large academic medical center. The training sample comprised encounters taking place between January 2020 and December 2021 (N = 204,723 encounters); the testing sample comprised data from encounters taking place between January and March 2022 (N = 28,631 encounters). The following empirically-supported features were evaluated: anxiety and sleep disorders (primary anxiety diagnosis, any anxiety diagnosis, primary sleep diagnosis, any sleep diagnosis), demographic characteristics (age, gender, race), medications (opioid prescription, number of opioid prescriptions, antidepressant prescription, antipsychotic prescription), other clinical variables (mood disorder, psychotic disorder, neurocognitive disorder, prescriber specialty), and insurance status (any insurance, type of insurance). We took a step-wise approach to developing a prediction model, wherein Model 1 included only anxiety and sleep diagnoses, and each subsequent model included an additional group of features. RESULTS: For predicting benzodiazepine prescription receipt (yes/no), all models showed good to excellent overall accuracy and area under the receiver operating characteristic curve (AUC) for both SVM (Accuracy = 0.868–0.883; AUC = 0.864–0.924) and RF (Accuracy = 0.860–0.887; AUC = 0.877–0.953). Overall accuracy was also high for predicting number of benzodiazepine prescriptions (0, 1, 2+) for both SVM (Accuracy = 0.861–0.877) and RF (Accuracy = 0.846–0.878). DISCUSSION: Results suggest SVM and RF algorithms can accurately classify individuals who receive a benzodiazepine prescription and can separate patients by the number of benzodiazepine prescriptions received at a given encounter. If replicated, these predictive models could inform system-level interventions to reduce the public health burden of benzodiazepines. |
format | Online Article Text |
id | pubmed-10036348 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-100363482023-03-25 Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach Kinney, Kerry L. Zheng, Yufeng Morris, Matthew C. Schumacher, Julie A. Bhardwaj, Saurabh B. Rowlett, James K. Front Psychiatry Psychiatry INTRODUCTION: Benzodiazepines are the most commonly prescribed psychotropic medications, but they may place users at risk of serious adverse effects. Developing a method to predict benzodiazepine prescriptions could assist in prevention efforts. METHODS: The present study applies machine learning methods to de-identified electronic health record data, in order to develop algorithms for predicting benzodiazepine prescription receipt (yes/no) and number of benzodiazepine prescriptions (0, 1, 2+) at a given encounter. Support-vector machine (SVM) and random forest (RF) approaches were applied to outpatient psychiatry, family medicine, and geriatric medicine data from a large academic medical center. The training sample comprised encounters taking place between January 2020 and December 2021 (N = 204,723 encounters); the testing sample comprised data from encounters taking place between January and March 2022 (N = 28,631 encounters). The following empirically-supported features were evaluated: anxiety and sleep disorders (primary anxiety diagnosis, any anxiety diagnosis, primary sleep diagnosis, any sleep diagnosis), demographic characteristics (age, gender, race), medications (opioid prescription, number of opioid prescriptions, antidepressant prescription, antipsychotic prescription), other clinical variables (mood disorder, psychotic disorder, neurocognitive disorder, prescriber specialty), and insurance status (any insurance, type of insurance). We took a step-wise approach to developing a prediction model, wherein Model 1 included only anxiety and sleep diagnoses, and each subsequent model included an additional group of features. RESULTS: For predicting benzodiazepine prescription receipt (yes/no), all models showed good to excellent overall accuracy and area under the receiver operating characteristic curve (AUC) for both SVM (Accuracy = 0.868–0.883; AUC = 0.864–0.924) and RF (Accuracy = 0.860–0.887; AUC = 0.877–0.953). Overall accuracy was also high for predicting number of benzodiazepine prescriptions (0, 1, 2+) for both SVM (Accuracy = 0.861–0.877) and RF (Accuracy = 0.846–0.878). DISCUSSION: Results suggest SVM and RF algorithms can accurately classify individuals who receive a benzodiazepine prescription and can separate patients by the number of benzodiazepine prescriptions received at a given encounter. If replicated, these predictive models could inform system-level interventions to reduce the public health burden of benzodiazepines. Frontiers Media S.A. 2023-03-10 /pmc/articles/PMC10036348/ /pubmed/36970256 http://dx.doi.org/10.3389/fpsyt.2023.1087879 Text en Copyright © 2023 Kinney, Zheng, Morris, Schumacher, Bhardwaj and Rowlett. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Psychiatry Kinney, Kerry L. Zheng, Yufeng Morris, Matthew C. Schumacher, Julie A. Bhardwaj, Saurabh B. Rowlett, James K. Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach |
title | Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach |
title_full | Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach |
title_fullStr | Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach |
title_full_unstemmed | Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach |
title_short | Predicting benzodiazepine prescriptions: A proof-of-concept machine learning approach |
title_sort | predicting benzodiazepine prescriptions: a proof-of-concept machine learning approach |
topic | Psychiatry |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036348/ https://www.ncbi.nlm.nih.gov/pubmed/36970256 http://dx.doi.org/10.3389/fpsyt.2023.1087879 |
work_keys_str_mv | AT kinneykerryl predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach AT zhengyufeng predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach AT morrismatthewc predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach AT schumacherjuliea predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach AT bhardwajsaurabhb predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach AT rowlettjamesk predictingbenzodiazepineprescriptionsaproofofconceptmachinelearningapproach |